PIK3CA and breast neoplasm: PIK3CA, which encodes the p110-alpha catalytic subunit of PI3K, has activating mutations in one-third of breast tumors, and although mutation rate of PTEN is less than 5 % [8], PTEN expression is found to be greatly diminished in at least 25 % of breast tumors and in near mutual exclusivity to PIK3CA mutation [9, 10].